FIELD: obstetrics. SUBSTANCE: female patient suffering from severe form of preeclampsia or eclampsia additionally receives 1.0 mg Delargin 7 to 48 h after the beginning of standard therapy. If necessary, administration of preparation is repeated 12-18 h later. EFFECT: enhanced treatment efficiency and lowered lethality. 2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ANESTHESIOLOGICAL ASSISTANCE AT OPERATIVE PARTURITION IN GESTOSIS-SUFFERING PREGNANT WOMEN | 2004 |
|
RU2286793C2 |
| METHOD FOR DELIVERY IN PATIENTS WITH GESTOSIS AT THE SECOND HALF OF PREGNANCY | 2003 |
|
RU2243003C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTENSIVE DISORDERS DURING PREGNANCY | 2010 |
|
RU2444280C2 |
| METHOD OF ANAESTHESIA CARE OF OPERATIVE DELIVERY IN WOMEN WITH SEVERE GESTOSIS | 2010 |
|
RU2436603C1 |
| METHOD OF TREATING PREECLAMPSIA OF MODERATE SEVERITY IN WOMEN WITH ALIMENTARY OBESITY | 2014 |
|
RU2549668C1 |
| METHOD FOR PREVENTION OF EARLY POSTPARTUM BLEEDING IN PATIENTS WITH HYPERTENSIVE DISORDERS DURING CESAREAN SECTION | 2022 |
|
RU2786814C1 |
| METHOD FOR PREDICTING THE RISK OF ECLAMPSIA DEVELOPMENT IN PREGNANT WOMEN | 2003 |
|
RU2243562C1 |
| METHOD OF PREDICTING PREECLAMPSIA THERAPY EFFICIENCY | 2011 |
|
RU2475753C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF MODERATE PREECLAMPSIA | 2020 |
|
RU2752715C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTENSIVE STATES IN PREGNANCY | 2012 |
|
RU2499547C1 |
